These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Effects of long-term treatment with anthranoids and sodium picosulphate on the contents of vasoactive intestinal polypeptide, somatostatin and substance P in the rat colon. Tzavella K, Schenkirsch G, Riepl RL, Odenthal KP, Leng-Peschlow E, Müller-Lissner SA. Eur J Gastroenterol Hepatol; 1995 Jan; 7(1):13-20. PubMed ID: 7532534 [Abstract] [Full Text] [Related]
7. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6. Delgado M, Martinez C, Pozo D, Calvo JR, Leceta J, Ganea D, Gomariz RP. J Immunol; 1999 Jan 15; 162(2):1200-5. PubMed ID: 9916753 [Abstract] [Full Text] [Related]
12. Immunocytochemical localization of GABA-, cholecystokinin-, vasoactive intestinal polypeptide-, and somatostatin-like immunoreactivity in the area dentata and hippocampus of the rat. Sloviter RS, Nilaver G. J Comp Neurol; 1987 Feb 01; 256(1):42-60. PubMed ID: 3819038 [Abstract] [Full Text] [Related]
19. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies. Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D. J Immunol; 1999 Feb 01; 162(3):1707-16. PubMed ID: 9973433 [Abstract] [Full Text] [Related]